Tarsus Pharmaceuticals, Inc. TARS Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s interest paid?
- Tarsus Pharmaceuticals, Inc. (TARS) reported interest paid of $1.97M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s interest paid changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s interest paid decreased by 5.1% year-over-year, from $2.07M to $1.97M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.